US Stock MarketDetailed Quotes
APVO Aptevo Therapeutics
- 0.471
- -0.110-18.93%
Close Jul 18 16:00 ET
- 0.435
- -0.036-7.66%
Pre 05:26 ET
3.63MMarket Cap-5P/E (TTM)
0.515High0.416Low11.07MVolume0.482Open0.581Pre Close5.12MTurnover143.80%Turnover RatioLossP/E (Static)7.70MShares50.16052wk High0.59P/B3.63MFloat Cap0.28552wk Low--Dividend TTM7.70MShs Float3911.600Historical High--Div YieldTTM17.11%Amplitude0.284Historical Low0.462Avg Price1Lot Size
Aptevo Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | -74.67%3.11M | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | -74.67%3.11M | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.97%6.98M | -9.06%28.88M | -16.92%6.38M | -15.71%6.56M | 8.15%8.18M | -11.11%7.76M | -5.75%31.76M | -0.27%7.68M | -0.79%7.78M | -14.38%7.56M |
| Selling and administrative expenses | -9.95%3.23M | -15.15%11.77M | -7.21%2.79M | -19.14%2.67M | -26.54%2.72M | -7.02%3.59M | -5.61%13.87M | -4.81%3.01M | -4.94%3.31M | -10.05%3.7M |
| -General and administrative expense | -9.95%3.23M | -15.15%11.77M | -7.21%2.79M | -19.14%2.67M | -26.54%2.72M | -7.02%3.59M | -5.61%13.87M | -4.81%3.01M | -4.94%3.31M | -10.05%3.7M |
| Research and development costs | -9.98%3.75M | -4.33%17.11M | -23.17%3.59M | -13.18%3.89M | 41.32%5.46M | -14.34%4.17M | -5.85%17.88M | 2.88%4.67M | 2.52%4.48M | -18.15%3.87M |
| Operating profit | 9.97%-6.98M | -0.83%-28.88M | 16.92%-6.38M | 15.71%-6.56M | -8.15%-8.18M | -38.23%-7.76M | -33.84%-28.64M | -90.20%-7.68M | -63.87%-7.78M | -32.16%-7.56M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -98.45%149K | -71.31%10.23M | -92.54%188K | 1,008.00%227K | -99.35%230K | 523.28%9.58M | 545.24%35.66M | 198.59%2.52M | 98.93%-25K | 1,612.51%35.42M |
| Special income (charges) | --0 | --9.65M | --0 | --0 | --0 | --9.65M | --0 | --0 | --0 | --0 |
| -Gain on sale of property,plant,equipment | --0 | --9.65M | --0 | --0 | --0 | --9.65M | --0 | --0 | --0 | --0 |
| Other non- operating income (expenses) | 322.39%149K | -98.38%578K | -92.54%188K | 1,008.00%227K | -99.35%230K | 97.04%-67K | 545.24%35.66M | 198.59%2.52M | 98.93%-25K | 1,612.51%35.42M |
| Income before tax | -474.06%-6.83M | -365.90%-18.65M | -20.01%-6.2M | 18.89%-6.33M | -128.53%-7.95M | 123.20%1.83M | 123.85%7.01M | 21.74%-5.16M | -10.34%-7.81M | 445.50%27.86M |
| Income tax | ||||||||||
| Net income | -346.45%-6.83M | -316.91%-17.41M | -27.17%-5.9M | 17.14%-6.33M | -128.38%-7.95M | 136.03%2.77M | 128.21%8.03M | 25.99%-4.64M | -9.25%-7.64M | 453.13%28.01M |
| Net income continuous Operations | -474.06%-6.83M | -365.90%-18.65M | -20.01%-6.2M | 18.89%-6.33M | -128.53%-7.95M | 123.20%1.83M | 123.85%7.01M | 21.74%-5.16M | -10.34%-7.81M | 445.50%27.86M |
| Net income discontinuous operations | --0 | 22.31%1.24M | -43.76%293K | --0 | --0 | 431.46%946K | 6.52%1.01M | 60.31%521K | 106.25%165K | 12.88%149K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -346.45%-6.83M | -316.91%-17.41M | -27.17%-5.9M | 17.14%-6.33M | -128.38%-7.95M | 136.03%2.77M | 128.21%8.03M | 25.99%-4.64M | -9.25%-7.64M | 453.13%28.01M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -346.45%-6.83M | -316.91%-17.41M | -27.17%-5.9M | 17.14%-6.33M | -128.38%-7.95M | 136.03%2.77M | 128.21%8.03M | 25.99%-4.64M | -9.25%-7.64M | 453.13%28.01M |
| Basic earnings per share | -157.25%-9.95 | -190.45%-62.48 | 68.08%-13.3414 | 66.67%-22 | -122.04%-54.12 | 125.48%17.38 | 125.86%69.08 | 25.20%-41.8 | -4.90%-66 | 418.86%245.52 |
| Diluted earnings per share | -157.25%-9.95 | -190.45%-62.48 | 68.08%-13.3414 | 66.67%-22 | -122.04%-54.12 | 125.48%17.38 | 125.86%69.08 | 25.20%-41.8 | -4.90%-66 | 418.86%245.52 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
